Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
23.18
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 986 | 1,231 | 1,785 | 2,963 | 1,354 | 1,114 | |
Market Cap Growth | -27.84% | -31.07% | -39.75% | 118.80% | 21.52% | 16.65% |
Enterprise Value | 1,384 | 1,611 | 2,165 | 3,336 | 1,273 | 1,106 |
Last Close Price | 23.18 | 26.78 | 37.13 | 61.85 | 28.02 | 23.29 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.74 | 12.55 | 11.19 | 21.54 | 14.82 | 17.94 |
Forward PE | 7.29 | 7.78 | 9.42 | 20.77 | 16.29 | 16.96 |
PS Ratio | 1.35 | 1.71 | 2.44 | 4.60 | 2.71 | 2.55 |
PB Ratio | 1.28 | 1.56 | 2.44 | 4.63 | 2.56 | 2.50 |
P/TBV Ratio | 8.19 | 5.52 | 12.60 | 113.42 | 2.76 | 2.74 |
P/FCF Ratio | 6.45 | 10.15 | 10.36 | 20.39 | 20.79 | 15.80 |
P/OCF Ratio | 5.34 | 7.88 | 8.37 | 16.15 | 15.19 | 11.37 |
PEG Ratio | - | 7.01 | 0.99 | 0.92 | 0.86 | 0.89 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.90 | 2.24 | 2.96 | 5.18 | 2.55 | 2.53 |
EV/EBITDA Ratio | 7.12 | 7.32 | 8.38 | 14.19 | 9.63 | 11.65 |
EV/EBIT Ratio | 10.08 | 9.85 | 10.54 | 16.93 | 11.85 | 15.43 |
EV/FCF Ratio | 9.05 | 13.29 | 12.56 | 22.95 | 19.55 | 15.68 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.90 | 0.83 | 0.89 | 0.98 | 0.19 | 0.24 |
Debt / EBITDA Ratio | 3.33 | 2.85 | 2.46 | 2.59 | 0.75 | 1.05 |
Debt / FCF Ratio | 4.50 | 5.41 | 3.78 | 4.29 | 1.58 | 1.48 |
Net Debt / Equity Ratio | 0.52 | 0.47 | 0.59 | 0.57 | -0.14 | -0.07 |
Net Debt / EBITDA Ratio | 2.05 | 1.70 | 1.66 | 1.56 | -0.55 | -0.34 |
Net Debt / FCF Ratio | 2.60 | 3.08 | 2.49 | 2.52 | -1.12 | -0.45 |
Asset Turnover | 0.44 | 0.45 | 0.47 | 0.57 | 0.71 | 0.67 |
Inventory Turnover | 2.06 | 2.20 | 2.76 | 2.80 | 2.55 | 2.51 |
Quick Ratio | 1.66 | 2.80 | 2.07 | 1.65 | 2.79 | 2.08 |
Current Ratio | 2.40 | 4.02 | 3.07 | 2.17 | 3.99 | 3.06 |
Return on Equity (ROE) | 10.30% | 12.90% | 23.26% | 23.55% | 18.76% | 14.16% |
Return on Assets (ROA) | 5.11% | 6.37% | 8.31% | 10.92% | 9.51% | 6.88% |
Return on Invested Capital (ROIC) | 9.06% | 11.17% | 15.98% | 21.89% | 19.68% | 13.13% |
Return on Capital Employed (ROCE) | 9.30% | 11.10% | 14.60% | 15.30% | 16.60% | 12.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.97% | 7.97% | 8.94% | 4.64% | 6.75% | 5.57% |
FCF Yield | 15.51% | 9.85% | 9.65% | 4.91% | 4.81% | 6.33% |
Buyback Yield / Dilution | 7.79% | 7.38% | 1.78% | -1.09% | -5.31% | -1.34% |